Cong Huang

Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending

Luwen Shi, A. Wagner, X. Guan, 2021, Cancer communications.

The impact of smoking status on the progression‐free survival of non‐small cell lung cancer patients receiving molecularly target therapy or immunotherapy versus chemotherapy: A meta‐analysis

Luwen Shi, Cong Huang, Xinyi Li, 2020, Journal of clinical pharmacy and therapeutics.

Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?

C. Ung, Luwen Shi, X. Guan, 2022, Health Research Policy and Systems.

Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017

Luwen Shi, X. Guan, Haishaerjiang Wushouer, 2020, Frontiers in Pharmacology.

Review of social networks of professionals in healthcare settings—where are we and what else is needed?

Luwen Shi, Chi Zhang, X. Guan, 2021, Globalization and Health.

Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis

C. Ung, Luwen Shi, X. Guan, 2021, International journal of health policy and management.

Psychotropic medication utilisation in adult cancer patients in China: A cross-sectional study based on national health insurance database

Luwen Shi, X. Guan, Lin Bai, 2020, The Lancet regional health. Western Pacific.

Differences of healthcare utilization and cost between cancer inpatients with and without depression: Based on national health insurance database

Luwen Shi, X. Guan, Tao Huang, 2021, Psycho-oncology.